Your browser version may not work well with NCBI's Web applications. More information here...
1: Curr Rheumatol Rep. 2007 Aug;9(4):291-7.Links

Advances in the immunobiology and treatment of inflammatory myopathies.

Neuromuscular Diseases Section, US National Institute of Neurological Disorders and Stroke, US National Institutes of Health, Building 10, Room 4N248, Bethesda, MD 20892, USA. dalakasm@ninds.nih.gov

The clinical spectrum and immunopathogenesis of inflammatory myopathies are summarized with an update on possible triggering factors, cell degeneration, and emerging new therapies.

PMID: 17688838 [PubMed - indexed for MEDLINE]